KANSAS CITY, Kan., July 23, 2018 /PRNewswire-PRWeb/ -- U.S. Dermatology Partners is pleased to announce the relocation
Plastic & Reconstructive Surgery opens its dedicated space on the first floor of the Dermatology & Skin Cancer Centers building, 7901 W. 135th St., Overland Park.
The practice is led by plastic surgeons Dr. Daniel Bortnick and Dr. Chris Surek. Dr. Bortnick is a board-certified plastic surgeon who is moving his office from Leawood as part of the expansion to better serve patients. Dr. Bortnick has served as an advisor, trainer and national speaker for major pharmaceutical companies. He has also served as an advisor for Allergan Breast Aesthetics, as a teaching faculty member for Allergan Academy, and as the director of the Cosmetic Plastic Surgery rotation at the University of Kansas Medical Center. Dr. Surek is a board-eligible plastic surgeon who recently completed an aesthetic surgery fellowship at the Cleveland Clinic and looks forward to offering comprehensive plastic, reconstructive and cosmetic surgery options with Dr. Bortnick.
The new space and addition of another physician will allow expanded services and availability for patients. The office includes 11 exam rooms, two procedure rooms, four consult rooms and an area dedicated to CoolSculpting, a noninvasive technique for freezing and shrinking fat cells.
The staff at Plastic & Reconstructive Surgery will take care of minor procedures in the office, as well as consult and advise on more extensive procedures, which are handled in credentialed surgery centers and hospitals. The location offers convenience for Dermatology & Skin Cancer Centers patients who need to consult on reconstructive work, especially related to Mohs Surgery closures.
For more information, visit http://www.drbortnick.com or http://www.surekplasticsurgery.com. To schedule an appointment, call 913-754-4939.
SOURCE U.S. Dermatology Partners
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All